Advisory Council

The Board of TOPRA is fortunate to be able to call on expert members of its Advisory Council for guidance. Appointed for terms of service of two years, the members of the Advisory Council cover many countries of the world and specialist areas.

All members of TOPRA can make recommendations to the Board, in confidence, for new Advisory Council members. The Council meets twice a year and provides a valuable external perspective on regulatory affairs and the needs of professionals in the discipline.

Council Members:

Peter Bachmann

Peter Bachmann

Federal Institute for Drugs and Medical Devices - BfArM (Germany)

Daniel Brasseur

Daniel Brasseur

Federal Agency for Medicines and Health Products - FAMHP (Belgium)

Daniela Drago - GW University

Daniela Drago

Biogen (USA)

Robert Johnstone

Robert Johnstone

Various patient associations (UK)

Rob Kowalski

Rob Kowalski

Novartis (USA)

Lawrence Liberti - CIRS

Lawrence Liberti

Centre for Innovation in Regulatory Science - CIRS (USA)

Murray Lumpkin - Gates Foundation

Murray Lumpkin

Bill & Melinda Gates Foundation (USA)

Ljiljana Markus-Cizelj

Zoetis BC (Croatia)

Alan Morrison - MSD

Alan Morrison


Ann O'Connor - Jazz Pharmaceuticals

Ann O'Connor

Jazz Pharmaceuticals (Ireland)

Pat O'Mahony - MMI

Pat O'Mahony

Clinical Research Development Ireland (CRDI)

Greg Perry - IFPMA

Greg Perry

International Federation of Pharmaceutical Manufacturers & Associations - IFPMA (Switzerland)

Tomas Salmonson - Swedish MPA

Tomas Salmonson

Consilium Salmonson & Hemmings

Rui Santos Ivo - INFARMED IP

Rui Santos Ivo

Infarmed I.P. - National Authority for Medicines and Health Products (Portugal)

Martina Struck - Kiniksa

Martina Struck

Kiniksa Pharmaceuticals

Mel Walker - Otsuka

Mel Walker

Otsuka (UK)

John Wilkinson - MHRA

John Wilkinson

Medicines & Healthcare products Regulatory Agency - MHRA (UK)